AJMC October 13, 2021
Researchers tested the feasibility of remote monitoring for patients with pulmonary arterial hypertension via smartphones and smartwatches.
Parallel monitoring of physical activity, heart rate, and iloprost inhalation is feasible among patients with pulmonary arterial hypertension (PAH), according to results of a prospective, multicenter, observational study. However, some challenges remain. Findings were published in Journal of Medical Internet Research.
PAH is a progressive disease that can lead to right-sided heart failure and death, while iloprost is a prostacyclin analog that can be inhaled through a nebulizer that tracks inhalation behavior.
“The impairment of quality of life in patients with PAH is severe, with health-related quality of life scores comparable to those reported for patients with spinal cord injuries or cancer unresponsive...
Today's Sponsors
Today's Sponsor